|
DNA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1094237467878E-15 |
| Normal-vs-Stage2 |
1.34980000510154E-08 |
| Normal-vs-Stage3 |
1.64013247427874E-12 |
| Normal-vs-Stage4 |
3.83904019685133E-12 |
| Stage1-vs-Stage2 |
1.587980E-01 |
| Stage1-vs-Stage3 |
2.325900E-02 |
| Stage1-vs-Stage4 |
1.176960E-04 |
| Stage2-vs-Stage3 |
6.917800E-01 |
| Stage2-vs-Stage4 |
1.585800E-02 |
| Stage3-vs-Stage4 |
2.236100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.34919999950078E-07 |
| Normal-vs-Asian |
7.782400E-03 |
| Caucasian-vs-AfricanAmerican |
4.038600E-01 |
| Caucasian-vs-Asian |
1.380720E-03 |
| AfricanAmerican-vs-Asian |
2.030100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.039900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.556670E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.788500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.292400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.139000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.767370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.016200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.356000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.637800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.143660E-02 |
| Normal-vs-Grade 2 |
1.4432899320127E-15 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
3.21800031066743E-10 |
| Grade 1-vs-Grade 2 |
3.448000E-01 |
| Grade 1-vs-Grade 3 |
9.203800E-01 |
| Grade 1-vs-Grade 4 |
4.749800E-01 |
| Grade 2-vs-Grade 3 |
2.626500E-02 |
| Grade 2-vs-Grade 4 |
3.363400E-03 |
| Grade 3-vs-Grade 4 |
7.783700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.11355369369903E-13 |
| ccA subtype-vs-ccB subtype |
8.349200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
8.206500E-04 |
| N0-vs-N1 |
2.908100E-02 |
|
|
